Liquid Biopsy Market Size, Share, and Analysis, By Product (Services, Kits & Reagents, and Platforms & Instruments), By Circulating Biomarker (Circulating Tumor DNA, Circulating Tumor Cell, Extracellular Vesicles, and Others), By Technology (Polymerase Ch

Liquid Biopsy Market Size, Share, and Analysis, By Product (Services, Kits & Reagents, and Platforms & Instruments), By Circulating Biomarker (Circulating Tumor DNA, Circulating Tumor Cell, Extracellular Vesicles, and Others), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Cytometry, Digital PCR), By Application (Diagnosis and Screening, Treatment Monitoring, Prognosis and Recurrence Monitoring, Treatment Selection), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW

Liquid Biopsy Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 15.3% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 5.1 billion and is projected to reach USD 24.7 billion by the completion of 2034.

Liquid biopsy is a non-invasive diagnostic test that identifies disease indicators in bodily fluids, such as blood. It is particularly useful in detecting genetic and molecular alterations, especially in cancer. Unlike traditional biopsies that require surgical procedures to obtain tissue samples, liquid biopsies involve a simple blood test or fluid sample collection, making the process less invasive and more accessible. Liquid biopsy is utilized for early cancer detection, monitoring treatment response, tracking disease progression, and identifying minimal residual disease and relapse. Techniques like Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Digital Droplet PCR are employed to detect and analyze genetic mutations, chromosomal abnormalities, and disease biomarkers. Beyond cancer, liquid biopsy is also used to test for genetic defects in unborn babies, monitor organ transplant rejection, and is becoming applicable in heart, infection-related, and immune system disorders.

MARKET HIGHLIGHTS

Liquid Biopsy Market is expected to reach USD 24.7 billion during the forecast period, driven by the increasing demand for non-invasive diagnostics. Liquid biopsy offers a less invasive alternative to traditional tissue biopsies, thus increasing its use for various diagnostic purposes. As global cancer cases continue to rise, there is a growing need for tools that can detect and monitor the disease in its early stages, leading to a higher demand for liquid biopsies. Additionally, advancements in technologies such as PCR, NGS, and Digital Droplet PCR enhance the precision and sensitivity of liquid biopsies, further fueling market growth. New technological advancements are also making liquid biopsies more accurate and affordable, making them more accessible to healthcare providers and patients.

Liquid Biopsy Market Segments:

• By Product
• Services
• Kits & Reagents
• Platforms & Instruments
• By Circulating Biomarker
• Circulating Tumor DNA
• Circulating Tumor Cell
• Extracellular Vesicles
• Others
• By Technology
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Cytometry
• Digital PCR
• By Application
• Diagnosis and Screening
• Treatment Monitoring
• Prognosis and Recurrence Monitoring
• Treatment Selection

MARKET DYNAMICS

Growth Drivers

Increasing Cancer Incidence is Critical to Boost the Adoption of Liquid Biopsy

Advancements in Technology Will Aid the Market

Restraint

High Costs Can Limit the Growth of the Liquid Biopsy Market

Key Players

• Guardant Health, Inc.
• QIAGEN N.V.
• Natera, Inc.
• Singular Genomics Systems, Inc.
• Exosome Diagnostics, Inc.
• Illumina, Inc.
• Asuragen, Inc.
• MDxHealth SA
• Thermo Fisher Scientific Inc.
• Epigenomics AG
• Sysmex Corporation
• Circulating Cell-Free Genome Atlas (CCGA)
• Foundation Medicine, Inc.
• Biocept, Inc.
• Roche Holding AG
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.

*Please Note: The report will be delivered in 2-3 business days upon order confirmation*